MALIGNANT PLEURAL MESOTHELIOMAS

Clinical trials for MALIGNANT PLEURAL MESOTHELIOMAS explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT PLEURAL MESOTHELIOMAS trials appear

Sign up with your email to follow new studies for MALIGNANT PLEURAL MESOTHELIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immune cells engineered to fight mesothelioma show promise in early trial

Disease control Recruiting now

This study tests a new treatment using specially engineered immune cells (CAR-NK cells) that target two markers found on mesothelioma tumors. The therapy is given directly into the chest or abdomen. The trial aims to find the safest dose and see if it can shrink tumors or slow di…

Matched conditions: MALIGNANT PLEURAL MESOTHELIOMAS

Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated May 17, 2026 05:29 UTC

MALIGNANT PLEURAL MESOTHELIOMAS

Get alerted when new MALIGNANT PLEURAL MESOTHELIOMAS trials appear

Immune cells engineered to fight mesothelioma show promise in early trial